FDA NDC Directory · JSON-LD · Markdown

Betamethasone Sodium Phosphate and Betamethasone Acetate

NDC 0517-0791 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION

Labeler / ManufacturerAmerican Regent, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090747
Dosage form / routeINJECTION, SUSPENSION · INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR
Active ingredientsBETAMETHASONE ACETATE (3 mg/mL)
BETAMETHASONE SODIUM PHOSPHATE (3 mg/mL)
Marketing started20191101
Package count1

External sources

Source: openFDA. Public-domain (CC0).